Sign In
Buy INSP
$51.36
-0.400 (-0.773%)
At Close: Jul 13, 2026
Inspire Medical Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems,
NEW YORK and NEW ORLEANS, July 10, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026
09:48am, Monday, 06'th Jul 2026
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- This press release corrects the earnings release date included in the earlier version issued on July 6, 2026. No other information has changed.
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
08:00am, Monday, 06'th Jul 2026
MINNEAPOLIS, July 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2026 after the close of trading on Monday, Aug
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
03:02pm, Friday, 26'th Jun 2026
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
11:31am, Monday, 22'nd Jun 2026
Inspire Medical's SLEEP 2026 updates spotlight new Inspire V data, remote patient tools and research supporting wider OSA therapy adoption.
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
08:00am, Tuesday, 16'th Jun 2026
Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
08:00am, Friday, 12'th Jun 2026
MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
11:49am, Thursday, 11'th Jun 2026
Alphatec bets on integrated spine surgery tech, while Inspire leads in sleep apnea devices with robust profitability. How do their financials and risks stack up?
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff
05:08am, Monday, 08'th Jun 2026
Inspire Medical Systems faces a sharp revenue slowdown due to temporary CPT coding and CMS Project WISeR disruptions, not fundamental business weakness. INSP maintains a robust balance sheet with ~$40
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
12:30pm, Wednesday, 03'rd Jun 2026
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
05:10pm, Wednesday, 13'th May 2026
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip
05:59pm, Tuesday, 05'th May 2026
Inspire Medical Systems, Inc. remains under pressure as Q1 revenue grew just 1.6% and management slashed 2026 guidance by up to 10%. INSP faces intensifying competition from GLP-1s and rival devices,
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down
12:50pm, Tuesday, 05'th May 2026
INSP beats Q1 estimates but slashes 2026 outlook as reimbursement disruptions and WISeR program weigh on growth and procedure volumes.
